Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Forbion European Acquisition Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/28/2023 8-K Investor presentation
Docs: "Presentation entitled “Development of a Non-Viral Gene Therapy Platform for Mucosal Tissues”",
"Presentation entitled “Development of a Non-Viral Gene Therapy Platform for Mucosal Tissues”"
06/06/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Working Capital Promissory Note dated June 6, 2023, issued by Forbion European Acquisition Corp. to Forbion Growth Sponsor FEAC I B.V",
"Extension Promissory Note dated June 6, 2023, issued by Forbion European Acquisition Corp. to Forbion Growth Sponsor FEAC I B.V"
05/17/2023 8-K Investor presentation
Docs: "enGene, Inc. and Forbion European Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies",
"Investor Presentation"
03/24/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
Docs: "Promissory Note dated March 24, 2023, issued by Forbion European Acquisition Corp. to Forbion Growth Sponsor FEAC I B.V",
"Promissory Note dated March 24, 2023, issued by Forbion European Acquisition Corp. to Forbion Growth Sponsor FEAC I B.V"
02/01/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Forbion European Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants Commencing February 1, 2022 Naarden, The Netherlands, February 1, 2022 - Forbion European Acquisition Corp. today announced that, commencing February 1, 2022, holders of the units sold in the Company's initial public offering of 12,650,000 units completed on December 15, 2021, including the 1,650,000 units sold pursuant to the exercise of the underwriters' over-allotment option, may elect to separately trade the shares of Class A common stock and warrants included in the units. Shares of Class A common stock and warrants that are separated will trade on the Nasdaq Global Market under the symbols “FRBN” and “FRBNW,” respectively. Those units not separated will continue to trade on the ..."
12/20/2021 8-K Other Events, Financial Statements and Exhibits
Docs: "Audited Balance Sheet, as of December 14, 2021"
12/15/2021 8-K Quarterly results
12/14/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy